Proliferation and differentiation of rat osteoporosis mesenchymal stem cells (MSCs) after telomerase reverse transcriptase (TERT) transfection
- PMID: 25796354
- PMCID: PMC4381855
- DOI: 10.12659/MSM.893144
Proliferation and differentiation of rat osteoporosis mesenchymal stem cells (MSCs) after telomerase reverse transcriptase (TERT) transfection
Abstract
Background: The aim of this study was to determine whether MSC are excellent materials for MSCs transplantation in the treatment of osteoporosis.
Material and methods: We studied normal, osteoporosis, and TERT-transfected MSC from normal and osteoporosis rats to compare the proliferation and osteogenic differentiation using RT-PCR and Western blot by constructing an ovariectomized rat model of osteoporosis (OVX). The primary MSC from model rats were extracted and cultured to evaluate the proliferation and differentiation characteristics.
Results: MSCs of osteoporosis rats obviously decreased in proliferation ability and osteogenic differentiation compared to that of normal rats. In contrast, in TERT-transfected MSC, the proliferation and differentiation ability, and especially the ability of osteogenic differentiation, were significantly higher than in osteoporosis MSC.
Conclusions: TERT-transfected MSCs can help osteoporosis patients in whom MSC proliferation and osteogenic differentiation ability are weak, with an increase in both bone mass and bone density, becoming an effective material for autologous transplantation of MSCs in further treatment of osteoporosis. However, studies are still needed to prove the in vivo effect, biological safety, and molecular mechanism of TERT-osteoporosis treatment. Additionally, because the results are from an animal model, more research is needed in generalizing rat model findings to human osteoporosis patients.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4381855/bin/medscimonit-21-845-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4381855/bin/medscimonit-21-845-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4381855/bin/medscimonit-21-845-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4381855/bin/medscimonit-21-845-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4381855/bin/medscimonit-21-845-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4381855/bin/medscimonit-21-845-g006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4381855/bin/medscimonit-21-845-g007.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4381855/bin/medscimonit-21-845-g008.gif)
![Figure 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4381855/bin/medscimonit-21-845-g009.gif)
![Figure 10](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4381855/bin/medscimonit-21-845-g010.gif)
![Figure 11](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4381855/bin/medscimonit-21-845-g011.gif)
Similar articles
-
Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis.Cell Prolif. 2021 Jan;54(1):e12956. doi: 10.1111/cpr.12956. Epub 2020 Nov 18. Cell Prolif. 2021. PMID: 33210341 Free PMC article. Review.
-
Decreased proliferation ability and differentiation potential of mesenchymal stem cells of osteoporosis rat.Asian Pac J Trop Med. 2014 May;7(5):358-63. doi: 10.1016/S1995-7645(14)60055-9. Asian Pac J Trop Med. 2014. PMID: 25063060
-
[A potential role for the bone marrow mesenchymal stem cell in the pathogenesis of osteoporosis by ovariectomy in rat].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2006 Feb;23(1):129-35. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2006. PMID: 16532827 Chinese.
-
Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia.Circ Res. 2013 Sep 13;113(7):902-14. doi: 10.1161/CIRCRESAHA.113.301690. Epub 2013 Jun 18. Circ Res. 2013. PMID: 23780385
-
[Osteogenic potential of bone marrow mesenchymal stem cells from ovariectomied osteoporotic rat].Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 May;36(3):318-21. Sichuan Da Xue Xue Bao Yi Xue Ban. 2005. PMID: 15931856 Chinese.
Cited by
-
Enhancing osteogenic differentiation in adipose-derived mesenchymal stem cells with Near Infra-Red and Green Photobiomodulation.Regen Ther. 2023 Nov 10;24:602-616. doi: 10.1016/j.reth.2023.11.003. eCollection 2023 Dec. Regen Ther. 2023. PMID: 38034860 Free PMC article.
-
The Wnt/β-catenin signaling pathway inhibits osteoporosis by regulating the expression of TERT: an in vivo and in vitro study.Aging (Albany NY). 2023 Oct 19;15(20):11471-11488. doi: 10.18632/aging.205136. Epub 2023 Oct 19. Aging (Albany NY). 2023. PMID: 37862118 Free PMC article.
-
Photobiomodulation: An Effective Approach to Enhance Proliferation and Differentiation of Adipose-Derived Stem Cells into Osteoblasts.Stem Cells Int. 2021 Mar 22;2021:8843179. doi: 10.1155/2021/8843179. eCollection 2021. Stem Cells Int. 2021. PMID: 33833810 Free PMC article. Review.
-
Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis.Cell Prolif. 2021 Jan;54(1):e12956. doi: 10.1111/cpr.12956. Epub 2020 Nov 18. Cell Prolif. 2021. PMID: 33210341 Free PMC article. Review.
-
Clinical plasma concentration of vinpocetine does not affect osteogenic differentiation of mesenchymal stem cells.Pharmacol Rep. 2021 Feb;73(1):202-210. doi: 10.1007/s43440-020-00153-8. Epub 2020 Aug 31. Pharmacol Rep. 2021. PMID: 32865810
References
-
- Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22:465–75. - PubMed
-
- Bandeira F, Costa AG, Soares Filho MA, et al. Bone markers and osteoporosis therapy. Arq Bras Endocrinol Metabol. 2014;58:504–13. - PubMed
-
- Adegani FJ, Langroudi L, Arefian E, et al. A comparison of pluripotency and differentiation status of four mesenchymal adult stem cells. Mol Biol Rep. 2013;40:3693–703. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical